CAR-T and Immunotherapy in Hemato-Oncology

Training Overview

CAR-T and Immunotherapy in Hemato-Oncology is an advanced, simulation-enhanced training program designed for hematologists, oncologists, immunotherapy specialists, transplant physicians, nurses, and trainees seeking in-depth expertise in cellular therapies, CAR-T workflows, toxicity management, and evidence-based treatment coordination. This two-day course integrates structured theoretical modules with case-driven simulations, emphasizing clinical decision-making, safety monitoring, and multidisciplinary management of patients receiving CAR-T and other immune-based therapies.

The program begins with foundational modules covering CAR-T engineering principles, target antigen selection, indication criteria, patient eligibility, bridging therapy planning, lymphodepletion strategies, infusion procedures, and post-infusion monitoring. Participants explore essential concepts such as immune activation mechanisms, biomarkers of response, neurotoxicity pathways, and cytokine-driven complications.

Hands-on simulation scenarios allow participants to practice full CAR-T care pathways using real-case datasets, toxicity scoring tools, and decision-support frameworks. Under expert supervision, attendees manage CRS and ICANS simulations, optimize supportive care, respond to emergencies, and coordinate multidisciplinary interventions from ICU to outpatient settings.

Through interactive case videos, scenario-based discussions, and tumor board–style reviews, participants analyze complex hematologic cancer cases involving therapeutic sequencing, toxicity mitigation, treatment resistance, immune escape patterns, and post-treatment surveillance. Structured feedback improves clinical reasoning, communication, and interdisciplinary collaboration.

By the end of the program, participants will have strengthened their ability to manage CAR-T therapy safely, interpret immune response patterns, triage complications, and integrate immunotherapy strategies across diverse hemato-oncology environments.

Target Audience

• Hematologists

• Medical Oncologists

• Immunotherapy Specialists

• Transplant Physicians

• Internal Medicine Physicians involved in oncology care

• Oncology & Cellular Therapy Nurses

• ICU Nurses managing CAR-T complications

• Residents and Fellows in Hematology/Oncology

• Clinical Pharmacists working in immunotherapy

• Clinical Coordinators and Cellular Therapy Program Staff

Training Specifics

Training Name: CAR-T and Immunotherapy in Hemato-Oncology

Duration: 2 full days

Language: English

Simulation Lab: High-fidelity CAR-T toxicity simulation stations, CRS/ICANS emergency response modules, immune response monitoring platforms

Assessment Type: Practical Evaluation & Quiz

Certificate: Certificate of Completion & CME Credits

Venue: ADN CoE Training, Research Center & Core Lab

Additional Benefits

• Hands-On CAR-T Simulation: Practice infusion workflows, toxicity scoring, acute CRS/ICANS management, and immune monitoring.

• Immunotherapy Mastery: Gain competence in treatment sequencing, patient selection, biomarker interpretation, and response evaluation.

• Complication Management: Strengthen skills in triaging toxicities, adjusting supportive care, and stabilizing high-risk patients.

• Workflow Optimization: Improve coordination across infusion teams, ICU support, pharmacy, and outpatient follow-up units.

• Faculty Guidance: Receive expert mentorship and structured feedback from leading hematology and immunotherapy specialists.

• Case-Based Learning: Analyze complex molecular profiles, relapse cases, and immune escape scenarios.

• Performance Enhancement: Build stronger decision-making, crisis management, and communication skills across multidisciplinary teams.

• Professional Advancement: Earn certification validating advanced competency in CAR-T and immunotherapy management.

Key Benefits

• Deep understanding of CAR-T therapy mechanisms, indications, and immune activation pathways.

• Improved ability to recognize and manage CRS, ICANS, and other immunotherapy-related toxicities.

• Enhanced clinical judgment for patient selection, bridging therapy, and post-treatment monitoring.

• Stronger collaboration among hematology, oncology, ICU, and supportive care teams.

• Increased readiness to manage CAR-T workflows with safety and confidence.

Ethical and Educational Standards

All ADN CoE training programs are designed in compliance with ethical, animal-free, and environmentally responsible education policies, ensuring clinical excellence and sustainability. For inquiries regarding accreditation or ethical compliance, contact trainings@adncoe.com.

Logistics and Additional Information

Transfer Services

Participants using ADN CoE accommodation and transfer options should adhere to the scheduled pick-up and drop-off times, which were shared before the training.

International Participants

Ensure your passport and visa are valid before travel. For invitation letters or official documentation, contact trainings@adncoe.com at least 4 weeks before the course start date. Information on nearby hotels, transport, and COVID-19 regulations will be provided before the event.

Attire

Business casual attire is recommended. Surgical scrubs and personal protective equipment will be provided for cadaver lab sessions. Please note: ADN CoE is a non-smoking, green-certified facility.

Health & Safety

Our venues comply with the highest safety and hygiene standards. Participants will receive orientation on fire, emergency, and biosafety protocols.

Transfer of Registration

Participants may transfer their registration to another individual from the same institution with prior written approval from ADN CoE, provided the request is made at least 10 days before the course start date.

Course Postponement or Cancellation

ADN CoE reserves the right to postpone or cancel the course due to unforeseen circumstances.

In case of cancellation by ADN CoE, participants will receive a full refund or the option to transfer to a future course date.

Non-Transferable Fees

Payment made for the course is non-transferable to other courses or services unless otherwise approved by ADN CoE.

Faculty Disclosure and Conflict of Interest 

All faculty members and proctors involved in this training disclose any financial or commercial interests. We maintain a strict policy of no conflict of interest with device companies, sponsors, or participants, ensuring unbiased and independent education.

Content Independence 

The educational content is developed based solely on the latest scientific evidence and clinical best practices. No product promotion or commercial advertising is included in our training materials.

Evaluation and Feedback 

We value your input. At the end of the course, you will be invited to complete a feedback survey and a knowledge assessment quiz. Your responses help us continually improve the training experience.

Quality Assurance 

Our training materials and curriculum are regularly reviewed and updated to reflect the most current research and technological advances in the field.

Sponsorship Transparency 

Any sponsorship or funding received for this course is disclosed upfront. We ensure that sponsors do not influence the content or delivery of the training.

Data Protection and Patient Confidentiality 

We strictly protect the privacy of all participants and uphold the highest standards of confidentiality regarding patient information shared during the training, in accordance with applicable data protection laws.

Accessibility and Inclusiveness 

We strive to make our training accessible to all participants. Language support and accommodations for disabilities are available upon request to ensure an inclusive learning environment.

If you have any questions about these policies or require assistance, please contact us at trainings@adncoe.com.

Please note that our trainings are specialized procedural trainings provided by ADN CoE. They are independent of any other training offered by relevant device companies.